EC
ELVN icon

EntryPoint Capital’s Enliven Therapeutics ELVN Stock Holding History

EntryPoint Capital’s Portfolio ELVN Stock Details ELVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-241
Closed -$5.63K – 760
2024
Q2 		$5.63K Sell
241
-9,269
-97% -$217K 0.01% 784
2024
Q1 		$167K Buy
+9,510
New +$167K 0.15% 169